dpp 4 inhibitors vs glp 1 agonist Insights into the Roles of GLP-1, DPP-4, and SGLT2 at the Crossroads of Cardiovascular, Renal, and Metabolic Pathophysiology DPP-4 inhibitors and GLP-1RAs: cardiovascular
Description
High levels of TNF- may repress endometrial GLUT-4 expression in PCOS via NFB activation, resulting in endometrium dysfunction (85, 86)
19-22 GLP-1 receptor agonists GLP-1 receptor agonists continue to grow in popularity for the treatment of T2DM due to their beneficial effects on glycemia and weight
Both pathways protect retinal cells (including RGCs) from damage induced by high glucose or ischemic conditions
Time course and mechanisms of the anti-hypertensive and renal effects of liraglutide treatment
[DOI] [PubMed] [Google Scholar] 525.Fujitani Y
